New PPF Guidelines Guidelines Previous Next FACE IPF HEAD ON and modify disease progression by slowing lung function decline Diagnosis and treatment of RA-ILD 21/11/2022 | Author: Boehringer IngelheimDiagnosis and treatment of RA-ILD Document ID: PC-AE-101579 | Expiry Date: 23/11/2024 Guidelines Diagnosis and treatment of RA-ILD RA-ILD identification ILD is the leading cause of mortality in SSc Identification & Management of SSc-ILD RELATED CONTENT Read more PDF Identification & Management of SSc-ILD PC-AE-101577 (November 2024 ) Download Opens in new tab Read more PDF ILD is the leading cause of mortality in SSc PC-AE-101576 (November 2024 ) Download Opens in new tab Read more PDF RA-ILD identification PC-AE-101578 (November 2024 ) Download Opens in new tab Home OFEV Guidelines Diagnosis and treatment of RA-ILD
Read more PDF Identification & Management of SSc-ILD PC-AE-101577 (November 2024 ) Download Opens in new tab
Read more PDF ILD is the leading cause of mortality in SSc PC-AE-101576 (November 2024 ) Download Opens in new tab